Verve Therapeutics
Pradeep Tangallapally is a Senior Analyst of Quality Control at Verve Therapeutics. Pradeep has over seven years of experience in the biotech industry.
Pradeep started their career as an Analytical Chemistry Co-op at Cubist Pharmaceuticals in January 2012. There, they provided research support for several projects, including running assays and method development for HPLC separation. Pradeep then became a NMR Co-op at Cubist Pharmaceuticals in January 2013 and held that position until August 2014.
In June 2015, Pradeep started working as a Senior Research Associate on the Biophysical & Formulation Team at Moderna. Pradeep worked there until February 2022 when they transitioned to their current role as a Senior Analyst of Quality Control at Verve Therapeutics.
Pradeep Tangallapally has a Bachelor of Science in Chemistry from Northeastern University.
Pradeep Tangallapally reports to Jeffrey Meltzer, VP, Quality. Pradeep Tangallapally works with Leocadia Ruiz - Senior Director, External Quality Control, Angela Gleason - Manager, Internal Quality Assurance, and Amanda Charlesworth - Manager, External Quality Control.
This person is not in any offices
Verve Therapeutics
59 followers
Verve Therapeutics is a biotechnology company focused on discovering and developing therapies that safely edit the genomes of adults to confer lifelong protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide.